You are here

  • Home
  • Archive
  • Volume 65, Issue 12
  • A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs

Citation Tools

Article menu
Download PDFPDF
Extended report
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Klareskog L, Gaubitz M, Rodriguez-Valverde V, et al
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs
Annals of the Rheumatic Diseases 2006;65:1578-1584.